| Breakdown | TTM | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.89M | 12.04M | 9.30M | 8.17M | 7.39M | 6.94M |
| Gross Profit | 4.10M | 3.64M | 2.17M | 1.44M | 1.64M | 1.55M |
| EBITDA | 1.19M | 804.47K | -521.60K | -2.31M | -1.85M | 428.22K |
| Net Income | 96.53K | -46.72K | -953.16K | -2.50M | -2.17M | 109.90K |
Balance Sheet | ||||||
| Total Assets | 7.31M | 8.32M | 8.33M | 7.07M | 8.54M | 4.64M |
| Cash, Cash Equivalents and Short-Term Investments | 1.07M | 1.21M | 981.36K | 590.67K | 3.86M | 39.14K |
| Total Debt | 1.73M | 1.93M | 2.37M | 2.94M | 2.51M | 2.37M |
| Total Liabilities | 4.99M | 5.84M | 5.87M | 5.13M | 4.62M | 3.82M |
| Stockholders Equity | 1.91M | 2.08M | 2.10M | 1.59M | 3.59M | 427.40K |
Cash Flow | ||||||
| Free Cash Flow | 2.33M | 1.51M | -451.82K | -3.38M | -2.29M | 12.27K |
| Operating Cash Flow | 2.37M | 1.53M | 175.57K | -2.75M | -1.98M | 486.38K |
| Investing Cash Flow | -866.11K | -577.66K | -457.42K | -627.37K | -305.05K | -974.71K |
| Financing Cash Flow | -1.47M | -723.18K | 672.54K | 110.41K | 6.11M | 652.84K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £65.18M | 3.57 | 22.93% | ― | 36.61% | ― | |
72 Outperform | £2.66B | 17.58 | 8.06% | 2.12% | 3.15% | -13.57% | |
69 Neutral | £274.41M | 31.22 | 12.26% | 1.89% | 5.46% | -26.44% | |
67 Neutral | £205.83M | 25.56 | 3.10% | 2.19% | 10.66% | 21.19% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £195.87M | -4.02 | -37.50% | ― | -16.33% | -448.12% | |
52 Neutral | £4.13M | -15.68 | ― | ― | ― | ― |